Evaluation of Membrane Phospholipid and Energy Metabolism in Subjects at High Risk of Psychotic Transition
Recruiting
N/A
Interventional Study
Patients With Ultra High Risk of Psychotic Transition
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 15 – 25
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 22 (estimated)
- Sponsor
- Centre Hospitalier Henri Laborit · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The management of schizophrenia is a major public health issue, due to its particularly disabling psychotic symptoms and their onset at an early age, typically in adolescents or young adults.
The physiopathological hypothesis of an anomaly relating to the renewal of cell membranes and energy metabolism in schizophrenia was proposed as early as the 1930s. This is based on anomalies at certain time…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria for the UHR group:
* Patient between 15 and 25 years old
* Patient fulfilling the UHR criteria objectified by the Comprehensive Assessment of At Risk Mental State scale (CAARMS) and by the social and professional functioning assessment scale (SOFAS) (the "Vulnerability" group is …
Contacts